ClinicalTrials.gg
CompletedNCT07891611Updated Oct 23, 2026

Effect of Combined Root Canal Therapies in Mandibular Molars With Coexistent Mature and Immature Apices on the Healing Outcome

An interventional study of Bioceramic apical plug and Regenerative endodontic procedure in Periapical Diseases, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 6 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Oct 2024, registered Oct 2026).
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
6 Years to 16 Years
Sex
All
01

Study summary

Recent advancements in dentistry are driven by the development of dental materials and therapies that support tissue regeneration, including the application of bioactive, biocompatible calcium silicate-based materials like mineral trioxide aggregate (MTA), Biodentine, and bioceramic sealers/putties, which facilitated the integration of different treatment protocols. These root canal treatment protocols can be implemented in the same tooth based on the specific stage of root development, such as combining conventional root canal treatment in the root with a closed mature apex, and regeneration or apical plug in the root with an open immature apex, thereby gaining the benefits of each protocol with a minimally invasive, more conservative approach. No research studies have been published evaluating the effect of combined different root canal treatment protocols on the management of molars with coexistent mature and immature apices. This study will evaluate the outcomes of combined root canal therapies in mandibular molars with coexistent mature and immature apices.

02

Conditions studied

  • Periapical Diseases

Browse trials for

03

In context

Periapical Diseases

46 studies on the registry are indexed under Periapical Diseases; 11 are open to participants now.

This study's enrollment of 50 is below the median of 60 across 37 interventional studies indexed under Periapical Diseases.

Browse Periapical Diseases studies →

Lead sponsor

Al-Azhar University is the lead sponsor of 525 studies on the registry; 171 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 6 to 16 years, of both sexes
  • ASA physical status I or II (American Society of Anesthesiologists classification)
  • Mandibular first or second permanent molar with non-vital (necrotic) pulp and two separate (non-fused) mesial and distal roots
  • Mature mesial root: Cvek stage V root development, apical diameter equal to or less than K-file ISO size 40, Weine type III canal configuration
  • Immature distal root: Cvek stage IV root development, apical diameter greater than K-file ISO size 40, Weine type I canal configuration
  • Restorable tooth (Class I or II of the classification of teeth with extensive endodontic damage)
  • Tooth mobility grade 0 or 1 (Miller classification)
  • Periodontal probing depth 0 to 3.5 mm (Community Periodontal Index score 0 to 2)
  • Periapical radiolucency 0 to 2 mm (Periapical Index score 0 to 2)
  • Pre-operative pain score 0 to 5 on the modified Verbal Descriptor Scale

Exclusion criteria

Exclusion Criteria:

  • ASA physical status III or IV
  • Uncooperative patients
  • Teeth with fused roots, a single root, or more than two roots
  • Teeth in which both the mesial and distal roots are mature, or both are immature
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Apical plug group

    Mandibular molars with a mature mesial root and an immature distal root, treated in two visits: a bioceramic apical plug in the immature distal root and conventional root canal treatment in the mature mesial root.

    Procedure: Bioceramic apical plug

  • Experimental
    Regeneration group

    Mandibular molars with a mature mesial root and an immature distal root, treated in two visits: a regenerative endodontic procedure in the immature distal root and conventional root canal treatment in the mature mesial root.

    Procedure: Regenerative endodontic procedure

Interventions

  • ProcedureBioceramic apical plug

    Two-visit treatment of mandibular molars with a mature mesial root and an immature distal root. After chemomechanical preparation (ProTaper Next; 2.5% sodium hypochlorite (NaOCl); final irrigation with 1.5% NaOCl, saline and 17% ethylenediaminetetraacetic acid (EDTA) with sonic activation), a 3 to 4 millimeter (mm) apical plug of bioceramic putty (Bio-C Repair, Angelus) is placed in the immature distal root using the Micro-Apical Placement (MAP) One system. At the second visit, the mature mesial canals are obturated with gutta-percha and a bioceramic sealer (Bio-C Sealer) using warm vertical compaction, and the tooth is restored with composite resin.

  • ProcedureRegenerative endodontic procedure

    Two-visit treatment of mandibular molars with a mature mesial root and an immature distal root. Visit 1: gentle irrigation of the immature distal canal with 1.5% sodium hypochlorite (NaOCl) and saline, then calcium hydroxide intracanal medication (Metapaste) for 2 weeks. Visit 2 (local anesthesia without vasoconstrictor): irrigation with saline and 17% ethylenediaminetetraacetic acid (EDTA), bleeding induced with a precurved size 25 K-file about 2 millimeters (mm) beyond the apex to form an intracanal blood clot, then a coronal barrier of bioceramic putty placed with the Micro-Apical Placement (MAP) One system and covered with glass ionomer. The mature mesial canals are obturated with gutta-percha and a bioceramic sealer using warm vertical compaction, and the tooth is restored with composite resin.

06

What researchers measure

Primary outcomes

  1. Periapical healing assessed by the Periapical Index (PAI)

    Periapical status of the treated tooth scored with the Periapical Index (PAI) on digital periapical radiographs at 3, 6 and 12 months, and on cone-beam computed tomography (CBCT) at 12 months. Lower scores indicate healthier periapical status. Reported as the number (%) of teeth in each PAI score category.

    Time frame: Baseline, 3, 6 and 12 months after treatment

Secondary outcomes

  1. Tenderness to percussion

    Number (%) of teeth with tenderness to percussion. Each tooth was percussed three times on the cusps with the shaft of a straight probe and scored as negative (no pain or discomfort) or positive (pain or discomfort compared with adjacent and contralateral teeth).

    Time frame: 3, 6 and 12 months after treatment

  2. Tenderness to palpation

    Number (%) of teeth with tenderness to palpation, assessed by firm digital pressure over the buccal and lingual cortical plates at the root apices and scored as negative (no tenderness) or positive (tenderness or pain).

    Time frame: 3, 6 and 12 months after treatment

  3. Presence of a sinus tract

    Number (%) of teeth with a sinus tract present on clinical examination.

    Time frame: 3 and 12 months after treatment

  4. Increased tooth mobility

    Number (%) of teeth with increased tooth mobility, graded with Miller's classification (grade 0, physiological; grade 1, slight; grade 2, moderate; grade 3, severe).

    Time frame: 12 months after treatment

  5. Postoperative pain intensity

    Pain intensity self-reported by patients on a modified Verbal Descriptor Scale (VDS) from 0 (no pain) to 10 (worst pain), using an Arabic-language form.

    Time frame: 24, 48, 72, 96 and 120 hours after treatment

  6. Postoperative swelling

    Swelling self-reported by patients on a four-point scale: 0 = none, 1 = mild intraoral swelling, 2 = moderate localized facial swelling, 3 = severe diffuse facial swelling.

    Time frame: 24, 48, 72, 96 and 120 hours after treatment

  7. Pattern of radiographic response of the immature distal root

    Radiographic response classified according to Chen et al.: type I, continued root maturation with canal wall thickening; type II, apex becomes blunt and closed without further root development; type III, continued root development with an open apex; type IV, severe canal calcification; type V, hard-tissue barrier formed in the canal. Reported as the number (%) of teeth of each type.

    Time frame: 12 months after treatment

07

Study locations

1 site
  • Faculty of Dental Medicine, Al-Azhar University (Boys, Cairo)
    Cairo, Egypt
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07891611
Responsible party
Mohamed Magdy Mahmoud Sayed Barakat (Principal Investigator, Al-Azhar University) — Principal investigator
First posted
Oct 23, 2026
Start date
Oct 1, 2024
Primary completion
Oct 1, 2026
Completion
Oct 1, 2026
Last update
Oct 23, 2026

Study contacts

Mohamed Magdy Barakat, BDS
principal investigator · Al-Azhar University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion